CLINICAL_TRIALS trial_result · 2017-11-17

Clinical Trial Update: DA-EPOCH-Rituximab/Metformin (RM) for Double Hit Lymphoma [Phase 2]

Phase 2 trial of DA-EPOCH-R Rituximab with Metformin for diffuse large B-cell lymphoma (double-hit) was terminated; results were posted in 2017.

Upgrade for the full analysis, importance score, and drug timeline.

Sponsor: Rush University Medical Center | Conditions: Diffuse Large B-Cell Lymphoma | Phase 2 | Status: TERMINATED | Results posted: 2017-11-17